Grown Rogue International (GRUSF) Net Income (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Net Income of -$2.2 million for Q1 2026, down 393.92% year-over-year from $753047.5 in Q1 2025, and up 100.0% quarter-over-quarter from -$6493.3 billion in Q4 2025.
Grown Rogue International (GRUSF) Net Income (2009 - 2026) Analysis & Trends
Grown Rogue International's Net Income history runs 18 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- In Q1 2026, Net Income fell 393.92% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$3504.5 billion (down 86541949.59% YoY), while the FY2025 annual figure was -$2.1 million, up 72.36% from the prior year.
- Net Income for Q1 2026 stood at -$2.2 million, up from -$6493.3 billion in the prior quarter.
- The five-year high for Net Income was $2988.8 billion in Q3 2025, with the low at -$6493.3 billion in Q4 2025.
- The 5-year median for Net Income is $411979.0 (2023), against an average of -$233.6 billion.
- Peak annual rise in Net Income reached 611045425.02% in 2025, while the deepest fall reached 530464593.19% in 2025.
- Grown Rogue International's Net Income stood at $122811.1 in 2022, then soared by 245.27% to $424032.7 in 2023, then soared by 188.68% to $1.2 million in 2024, then plunged by 530464593.19% to -$6493.3 billion in 2025, then soared by 100.0% to -$2.2 million in 2026.
- Business Quant data shows GRUSF's Net Income at -$2.2 million in Q1 2026, -$6493.3 billion in Q4 2025, and $2988.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -1.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.48 Mn |
| Mar 31, 2026 | -2.21 Mn |
| Dec 31, 2025 | -6,493.31 Bn |
| Sep 30, 2025 | 2,988.77 Bn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 753,047.52 |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | -489,123.29 |
| Jun 30, 2024 | -5.54 Mn |
| Mar 31, 2024 | -3.09 Mn |
| Dec 31, 2023 | 424,032.67 |
| Oct 31, 2023 | -925,449.37 |
| Jul 31, 2023 | 567,497.16 |
| Apr 30, 2023 | 411,979.00 |
| Jan 31, 2023 | 439,303.63 |
| Jan 31, 2022 | 122,811.08 |
| Oct 31, 2021 | 877.00 Bn |
| Jul 31, 2021 | 195.60 Bn |
| Jan 31, 2021 | 995,789.00 |
| Oct 31, 2020 | -4.59 Mn |